ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2019

A Novel MRI Scoring System for the Evaluation of Early-Stage Disease Activity of the Wrist in Juvenile Idiopathic Arthritis

Charlotte M. Nusman1, Robert Hemke1, Taco W. Kuijpers2, Eline E. Deurloo1, Dieneke Schonenberg3, J. Merlijn Van den Berg4, Koert M. Dolman5, Marion A.J. Van Rossum4 and Mario Maas1, 1Department of Radiology, Academic Medical Center, Amsterdam, Netherlands, 2Pediatric Rheumatology and Immunology, Emma Children's Hospital/Academic Medical Center (AMC), Amsterdam, Netherlands, 3Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 4Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center and Reade Institute, Amsterdam, Netherlands, 5Pediatric Rheumatology, St. Lucas Andreas Hospital and Reade Institute, Amsterdam, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), magnetic resonance imaging (MRI) and outcome measures

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Evidence that early therapeutic intervention prevents structural damage in juvenile idiopathic arthritis (JIA) patients requires focus on early-stage disease activity scores. Most outcome measures in JIA, such as the validated paediatric-targeted MRI scoring system (PTMRIS)1, are based on adult equivalents with extensive focus on late-stage structural damage. Using our recently validated juvenile arthritis MRI scoring system (JAMRIS) for the knee2, we have developed a similar analysis tool for the wrist to assess disease activity at an early stage. This focus shift to early-stage disease activity is achieved through extending soft tissue structure scores and specifying the grading of bone items affecting <25% of the bone.  The objectives of this study were (1) to assess the intra- and interreader reliability of the JAMRIS system for the evaluation of early-stage disease activity in the wrist and (2) to compare the reliability of JAMRIS and PTMRIS.

Methods:

MRI datasets from 20 JIA patients with wrist involvement were evaluated independently by three readers using JAMRIS and PTMRIS. JAMRIS for the wrist comprises synovial hypertrophy (6 locations, grading from 0-3), tenosynovitis (2 locations, grading from 0-1), bone marrow changes (15 locations, grading from 0-3) and bone erosions (15 locations, grading from 0-3) as scoring items. The intraclass correlation coefficient (ICC) or Cohen’s kappa was used to assess inter- and intrareader reliability. The ICC of each JAMRIS scoring item was compared with the ICC of its equivalent in PTMRIS.

Results:

The interreader reliability (ICC or Cohen’s kappa) of JAMRIS varied from 0.62 to 0.89. Interreader reliability for tenosynovitis score was low (0.24 to 0.48). Intrareader reliability (ICC or Cohen’s kappa) of JAMRIS varied with from 0.28 to 0.95 for reader 1 and from 0.41 to 0.97 for reader 2. JAMRIS and PTMRIS showed similar results of interreader reliability.

Conclusion:

Early-stage JIA disease activity in the wrist can be reliably evaluated with three-out-of-four JAMRIS scoring items. JAMRIS, especially focussed on early-stage disease presentation, has comparable reliability to PTMRIS. Correlating clinical disease assessment and responsiveness to change will be needed to validate JAMRIS for the wrist as outcome measure and disease monitoring tool.

References

1          Malattia C, Damasio MB, Pistorio A, Ioseliani M, Vilca I, Valle M et al. Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis. Ann Rheum Dis 2011; 70(3):440-446.

2          Hemke R, van Rossum MA, van Veenendaal M, van den Berg JM, Dolman KM, Kuijpers TW et al. The Reliability of a New Juvenile Arthritis MRI Scoring System for the Knee; JAMRIS. [abstract]. Arthritis Rheum 2011;63 Suppl 10:956


Disclosure:

C. M. Nusman,
None;

R. Hemke,
None;

T. W. Kuijpers,
None;

E. E. Deurloo,
None;

D. Schonenberg,
None;

J. M. Van den Berg,
None;

K. M. Dolman,
None;

M. A. J. Van Rossum,
None;

M. Maas,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-mri-scoring-system-for-the-evaluation-of-early-stage-disease-activity-of-the-wrist-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology